Patents by Inventor Joseph J. LUNDQUIST
Joseph J. LUNDQUIST has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210246419Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: ApplicationFiled: January 27, 2021Publication date: August 12, 2021Applicant: Humacyte, Inc.Inventors: Shannon L.M. DAHL, Laura E. NIKLASON, Justin T. STRADER, William E. TENTE, Joseph J. LUNDQUIST, Juliana Blum, Heather L. Prichard
-
Patent number: 10947498Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: GrantFiled: June 13, 2018Date of Patent: March 16, 2021Assignee: humacyte, inc.Inventors: Shannon L. M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
-
Patent number: 10934522Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: GrantFiled: May 8, 2018Date of Patent: March 2, 2021Assignee: Humacyte, Inc.Inventors: Shannon L. M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
-
Patent number: 10619132Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: GrantFiled: May 15, 2017Date of Patent: April 14, 2020Assignee: Humacyte, Inc.Inventors: Shannon L. M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
-
Publication number: 20180291333Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: ApplicationFiled: June 13, 2018Publication date: October 11, 2018Applicant: Humacyte, Inc.Inventors: Shannon L.M. DAHL, Laura E. NIKLASON, Justin T. STRADER, William E. TENTE, Joseph J. LUNDQUIST
-
Publication number: 20180251727Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: ApplicationFiled: May 8, 2018Publication date: September 6, 2018Applicant: Humacyte, Inc.Inventors: Shannon L.M. DAHL, Laura E. NIKLASON, Justin T. STRADER, William E. TENTE, Joseph J. LUNDQUIST
-
Publication number: 20170306292Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: ApplicationFiled: May 15, 2017Publication date: October 26, 2017Inventors: Shannon L.M. DAHL, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
-
Patent number: 9657265Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: GrantFiled: September 24, 2014Date of Patent: May 23, 2017Assignee: Humacyte, Inc.Inventors: Shannon L. M. Dahl, Laura E. Niklason, Juliana Blum, Justin T. Strader, William E. Tente, Heather L. Prichard, Joseph J. Lundquist
-
Publication number: 20170135805Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: ApplicationFiled: January 31, 2017Publication date: May 18, 2017Inventors: Shannon L.M. DAHL, Laura E. NIKLASON, Juliana BLUM, Justin T. STRADER, William E. TENTE, Heather L. PRICHARD, Joseph J. LUNDQUIST
-
Patent number: 9650603Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: GrantFiled: September 24, 2014Date of Patent: May 16, 2017Assignee: Humacyte, Inc.Inventors: Shannon L. M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
-
Patent number: 9556414Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: GrantFiled: January 6, 2012Date of Patent: January 31, 2017Assignee: HUMACYTEInventors: Shannon L. M. Dahl, Laura E. Niklason, Juliana Blum, Justin T. Strader, William E. Tente, Heather L. Prichard, Joseph J. Lundquist
-
Publication number: 20150031131Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: ApplicationFiled: September 24, 2014Publication date: January 29, 2015Inventors: Shannon L.M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
-
Publication number: 20150012083Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.Type: ApplicationFiled: September 24, 2014Publication date: January 8, 2015Inventors: Shannon L.M. Dahl, Laura E. Niklason, Juliana Blum, Justin T. Strader, William E. Tente, Heather L. Prichard, Joseph J. Lundquist
-
Publication number: 20130013083Abstract: Constructs including a tubular biodegradable polyglycolic acid scaffold may be coated with extracellular matrix proteins and are substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, an arterial graft, a venous graft, a duct graft, a skin graft, or a urinary graft or conduit.Type: ApplicationFiled: July 5, 2012Publication date: January 10, 2013Applicant: HUMACYTEInventors: Juliana L. BLUM, Shannon L.M. DAHL, Laura E. NIKLASON, Justin T. STRADER, William E. TENTE, Heather L. PRITCHARD, Joseph J. LUNDQUIST